2016, Outstanding Student Award, University of Washington School of Public Health
2014, Comparative Effectiveness Research Pre-Doctoral Fellowship, University of Washington School of Pharmacy
2014, Healthcare Career Scholarship, Korean American Healthcare Professional Association (KAHPA)
2012-14 Pre-doctoral National Research Service Award (NRSA) Fellowship, Agency for Healthcare Research and Quality (AHRQ)
2011, Cancer Epidemiology Education in Special Population Fellowship, University of Michigan School of Public Health
1. Kim, DD, Basu, A, Duffy, SQ, and Zarkin, GA. Appendix A. Worked Example 1: Cost-effectiveness of treatments for individuals with alcohol use disorders: A reference case analysis. In Neumann, P. et al. (Eds.), Cost-effectiveness in Health and Medicine (2nd Edition). NY: Oxford University Press. 2016.
2. Kim, DD and Basu, A. Estimating the medical care costs of obesity in the US: Systematic review, meta-analysis, and empirical analysis. Value in Health. 2016; 19(5): 602-613.
3. Kim, DD, Hutton, DW, Raouf, AA, Salama, M., Hablas, A., Seifeldin, IA and Soliman, AS. Cost-effectiveness model for Hepatitis C screening and treatment: Implications for Egypt and other countries with high prevalent. Global Public Health. 2015; 10(3): 296-31.
4. Stein, JD, Newman-Casey, PA, Kim, DD, Nwanyanwu, KS, Johnson, MW and Hutton, DW. Cost-effectiveness of different interventions for treating patients with newly diagnosed diabetic macular edema. Ophthalmology. 2013; 120(9): 1835-1842.
5. Stein, JD, Kim, DD, Peck, WW, Giannetti, SM and Hutton, DW. (2012) Cost-effectiveness of glaucoma medications and laser trabeculoplasty in the treatment of patients with newly-diagnosed open-angle glaucoma. JAMA Ophthalmology. 2012; 130(4): 497-505.
View all publications in PubMed.
David D. Kim, PhD, is an Assistant Professor at the Center for the Evaluation of Value and Risk in Health at the Tufts Medical Center Institute for Clinical Research and Health Policy Studies. His research focuses on using cost-effectiveness analysis in health policy decision-making, developing models to evaluate the economic value of health policy and medical interventions, and improving research prioritization using a value of information analysis. His previous work includes evaluating cost-effectiveness of medical interventions, such as bariatric surgery, hepatitis c screening, and treatment in Egypt, glaucoma medications, diabetic macular edema treatment. Also, he was a lead author of the worked example included in the recently updated textbook, Cost-Effectiveness in Health and Medicine, second edition. David received his doctorate in Health Services with a concentration in Health Economics from the University of Washington in 2016 and his MS in Biostatistics from the University of Michigan School of Public Health.